Latest Administration News

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

HUB24 Limited reported robust FY25 results with revenue climbing 24% to $406.6 million and underlying net profit after tax soaring 44%. The company’s platform funds under administration grew 34%, underpinning a 47% increase in fully franked dividends.

Income Asset Management announces key board retirements and appointments set for November 2025, aiming to strengthen governance and accelerate growth.

Top Shelf International Holdings Limited has appointed voluntary administrators amid financial distress, with plans to continue trading while exploring sale or recapitalisation options. Shares remain suspended as the company seeks a path forward.

New Hope Corporation reported robust FY25 coal production and EBITDA despite severe weather and logistics disruptions at its Bengalla Mine, while New Acland Mine showed significant growth.

Lumos Diagnostics has submitted its CLIA waiver application for FebriDx® to the FDA, backed by strong clinical data and triggering significant milestone payments. Approval could expand the U.S. market opportunity fifteen-fold to over $1 billion.

Fiducian Group reported robust FY2025 results, showcasing significant growth in funds under management and administration alongside a strong dividend payout. The company’s fintech innovation and adviser expansion underpin its steady momentum.

Amcor plc reported a 10% increase in net sales for fiscal 2025 following its merger with Berry Global Group, Inc., yet net income fell 30% amid significant integration expenses and higher debt costs. The company aims to unlock $530 million in synergies by 2028 while navigating global economic and operational risks.

Truscott Mining Corporation has confirmed a $577,890 capital raise through a rights issue, explaining its exploration expenditure and operational status amid a drilling hiatus since late 2022. The company underscores its commitment to long-term project development and compliance with ASX listing requirements.

Fortuna Metals Limited has officially changed its name from Lanthanein Resources Ltd and updated its ASX ticker from 'LNR' to 'FUN', effective 20 August 2025. The company also unveiled a new website and detailed its post-consolidation capital structure.

Neurizon Therapeutics faces a delay in FDA review for its lead ALS therapy NUZ-001, with a new decision expected by early October amid agency-wide staffing challenges.

WA1 Resources has raised A$100 million through a placement to accelerate pre-development and infrastructure work at its Luni Niobium Project, bolstering its cash reserves to A$168 million.